Announcement summary: China Railway consortium won 22.092 billion yuan project

category:Finance
 Announcement summary: China Railway consortium won 22.092 billion yuan project


Bank of Jiangsu: the first donation of 10 million yuan to support the prevention and control of new crown pneumonia

On the evening of February 5, Bank of Jiangsu (600919) announced that in order to fully support Wuhan in fighting the epidemic and actively fulfill its corporate social responsibility, the board of directors of the company agreed to donate 10 million yuan to the first batch of Jiangsu medical team to support the prevention and control of new crown pneumonia.

Dirui medical (300396) announced in the evening of February 5 that in order to practice corporate social responsibility and actively participate in the fight against the new coronavirus epidemic, after several days of actual docking with the diagnosis and treatment hospital, through the research of the board of directors, it donated about 10 million yuan worth of medical testing agents and instruments to the fight against the epidemic area, considering the installation, commissioning, after-sales service and traffic management of the instruments The board of directors has made it clear that the donation mode is targeted donation by designated hospitals to fight against the epidemic. The donation includes blood cell analysis, urine analysis and other hospital needs testing equipment and supporting reagents and other products.

Qianyuan medicine: donate 2 million yuan worth of drugs to support epidemic prevention and control

Qianyuan Pharmaceutical (300254) announced in the evening of February 5 that the company will donate 2 million yuan worth of drugs to the epidemic area through the Pingcheng District Red Cross Society of Datong City, Shanxi Province, including: mezlocillin sodium for injection, Sulbactam Sodium for respiratory system, ambroxol hydrochloride dispersible tablets, to support the epidemic area to do a good job in the prevention and control of pneumonia caused by new coronavirus infection.

Shouxiangu: the subsidiary has donated 4.04 million yuan of products

Shouxiangu (603896) announced in the evening of February 5 that Jinhua shouxiangu Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, has donated a total of 4.0428 million yuan to foreign countries, such as shouxiangu Ganoderma lucidum spore powder (broken wall), shouxiangu Tiepi Fengdou granules and other products. It has donated five times to the first-line medical workers, such as the staff of the emergency medical team of Zhejiang Province to fight against new crown pneumonia, to relieve fatigue and improve immunity, Strengthen the physique, resist the virus, and help the medical staff to fight against the epidemic with practical actions.

Winning bid

China Railway: the consortium won the bid of 22.092 billion yuan highway project

China Railway (601390) announced on the evening of February 5 that recently, the company, together with its wholly-owned subsidiary, China Railway Erju group and other parties, won the bid for the government and social capital partnership (PPP) project of national highway 109 New Line Expressway (West Sixth Ring Road to municipal boundary section). Social investors and government investment representatives plan to jointly invest and implement the project with a 60%: 40% equity ratio The investment is 22.092 billion yuan.

China Railway Construction: the consortium won 15.5 billion yuan of the project

China Railway Construction (601186) announced on the evening of February 5 that recently, China Railway 14th Bureau Group Co., Ltd., a subsidiary of the company, as a member of the consortium, won the bid for the Fenghuangling industrial and urban integration project in Hedong District, Linyi city. The project adopts the mode of social investor + EPC, which is implemented by stages and developed in a rolling way. The total investment of the project is about 15.5 billion yuan.

Jindun Co., Ltd.: won 21.2 million yuan Wind Turbine Project

Jindun Co., Ltd. (300411) announced in the evening of February 5 that the company became the bid winner of wind turbine (domestic) of Wanda real estate group cost management center. The company has won the annual centralized purchase project of Wanda real estate group for 4 consecutive years. The total bid winning amount of this project is 21.1994 million yuan, accounting for 3.83% of the companys operating revenue in 2018.

Increase holdings and reduce holdings

Shenneng shares: 5% of shares held by Yangtze Power

Shenneng Co., Ltd. (600642) announced on the evening of February 5 that the shareholder Changjiang Electric Power Co., Ltd. increased 743000 shares on February 5, accounting for about 0.0151% of the total share capital of the company. After this increase, Changjiang Electric Power Co., Ltd. holds 5% of the companys shares in total.

Will pharmaceutical: shareholders and supervisors plan to reduce the total number of shares by no more than 1.6%

Yongxing materials: shareholders plan to reduce their shares by no more than 2%

Yongxing materials (002756) announced in the evening of February 5 that Yang Jinmao, a 4.37% shareholder, planned to reduce his holding of no more than 7.2 million shares, or no more than 2% of the companys total share capital, by means of centralized bidding within six months after three trading days.

Zhongheng Electric: the actual controller and its concerted actors plan to reduce their shares by no more than 3.18%

Zhongheng electric (002364) announced in the evening of February 5 that Zhu Guoding, the actual controller of the company, and Bao Xiaoru, the person acting in concert with him, planned to reduce their holdings by no more than 17929800 shares in total within 6 months after 15 trading days, accounting for 3.18% of the total share capital of the company.

hare repurchase

Binhua shares: to repurchase shares of RMB 100-200 million

Binhua shares (601678) disclosed the plan for share buyback on the evening of February 5. The total amount of the buyback fund is not less than 100 million yuan, not more than 200 million yuan, and the price of the buyback shares is not more than 7.50 yuan / share. The buyback shares are used to convert the convertible corporate bonds issued by the company.

Zhangyuan tungsten: to repurchase shares of RMB 35 million to RMB 70 million

Zhangyuan tungsten industry (002378) announced on the evening of February 5 that it planned to use its own funds to repurchase part of the public shares in the form of centralized competitive trading for the implementation of equity incentive. The total amount of funds to be repurchased shall not be less than 35 million yuan and not more than 70 million yuan, and the repurchase price shall not be more than 6 yuan / share.

Important matters

Sincerity pharmaceutical: the companys drugs pass the conformity evaluation of generic drugs

Sincerity Pharmaceutical (603811) announced on the evening of February 5. Recently, the company learned through the website of the State Drug Administration that glucosamine hydrochloride capsule (specification: 240mg) has passed the quality and efficacy consistency evaluation of generic drugs. The consistency evaluation of the drug should be conducive to expanding market share.

Yanan Bikang: the total investment of the production line project of epidemic control and protection products such as masks is planned to be no more than 50 million yuan

Yanan Bikang (002411) announced in the evening of February 5 that at present, the company is promoting the change of business scope of Bikang Xinyi, the main investment and construction body of the production line project of epidemic control protection products such as masks, and obtaining the production and business license of masks and other related products through the green channel of the government as soon as possible, which is expected to be completed in the middle of February. Pre communication has been completed on the procurement of production equipment and raw and auxiliary materials. It is expected that the equipment and materials required for production can be delivered to the site for commissioning and installation in mid February and reach the planned capacity by the end of February. The total investment amount of the production line project of the respirator and other epidemic control and protection products is proposed to be no more than 50 million yuan.

Gaolan Co., Ltd.: Dongguan Sixiang has limited influence on the companys performance

Dongfeng Co., Ltd.: the subsidiary is actively carrying out trial production of goggles for medical protective equipment

Dongfeng Co., Ltd. (601515) announced on the evening of February 5 that, in accordance with the instructions of Guizhou Province on the prevention and control of new coronavirus pneumonia, its holding subsidiary, Qianye pharmaceutical packaging Co., Ltd. is currently actively carrying out the trial production of goggles for medical protective articles, and urgently resuming the production of pharmaceutical packaging materials such as PVC and PET plastic bottles according to the needs of pharmaceutical enterprises customers, so as to assist customers in ensuring the continuity of anti epidemic medical articles Continuous production and supply.

Tianjin Port: Chairman Liang yongcen resigns due to job change

Tianjin Port (600717) announced on the evening of February 5 that Liang yongcen was appointed Vice Chairman and general counsel of Tianjin Port (Group) Co., Ltd. due to the change of work. He applied to resign as chairman and director of the company, and at the same time resigned from the corresponding duties of the professional committee of the ninth board of directors. In addition, due to the change of work, Liu Qingshun served as the vice president of Tianjin Port (Group) Co., Ltd., applied to resign as the president of the company and continue to serve as the director of the company and member of the professional committee of the board of directors.

Qingsong Co., Ltd.: Qingsong Co., Ltd. (300132) announced in the evening of February 5 that its subsidiary purchased medical mask production equipment and obtained emergency medical device production record certificate. Northbell, the holding subsidiary of the company, recently purchased medical mask production equipment and applied to Zhongshan municipal market supervision and Administration Bureau for obtaining emergency medical device production record certificate during the first level response to public health emergencies in Zhongshan City Certificate. Northbell, the company and its holding subsidiary, has not been engaged in the business activities of medical mask production before. This time, northbell purchased medical mask production equipment and produced medical masks, only to solve the problem of insufficient supply of medical masks for epidemic prevention and control. The companys main business has not changed, and the production of medical masks has no significant impact on the companys business performance. Source: editor in charge of Finance and economics of Netease: Liu Songgou nbj9949

Qingsong Co., Ltd.: subsidiary company purchases medical mask production equipment and obtains emergency medical device production record certificate

Qingsong Co., Ltd. (300132) announced in the evening of February 5 that northbell, the holding subsidiary of the company, recently purchased medical mask production equipment and applied to Zhongshan municipal market supervision and Administration Bureau for obtaining the certificate of emergency medical device production record during the first level response period of public health emergencies in Zhongshan City. Northbell, the company and its holding subsidiary, has not been engaged in the business activities of medical mask production before. This time, northbell purchased medical mask production equipment and produced medical masks, only to solve the problem of insufficient supply of medical masks for epidemic prevention and control. The companys main business has not changed, and the production of medical masks has no significant impact on the companys business performance.